{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:49:56Z","timestamp":1783446596132,"version":"3.55.0"},"reference-count":36,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43TW009345"],"award-info":[{"award-number":["D43TW009345"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Infection"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hyperuricemia is associated with an elevated risk of cardiovascular diseases (CVD) among people with HIV (PLWH). However, there is a paucity of studies examining the factors associated with hyperuricemia among PLWH in sub-Saharan Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aimed to determine the prevalence and factors associated with hyperuricemia among PLWH at a tertiary hospital in Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>We conducted a cross-sectional study among PLWH receiving antiretroviral therapy (ART) at the HIV clinic at Kiruddu National Referral Hospital in Kampala, Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Data were collected using a structured questionnaire, anthropometric and blood pressure measurements, and analysis of fasting blood glucose, blood lipids, glycated hemoglobin, and serum uric acid of blood samples from participants. Modified Poisson regression with robust standard errors was used to assess factors associated with hyperuricemia. Statistical significance was set at\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.05 for all analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 390 PLWH, the mean (SD) age was 41.4 (12.3) years, and 209 (53.6%) were female. A total of 360 (92.3%) were on dolutegravir-based ART regimens, and 94.7% (306\/323) were virally suppressed (viral load\u2009&lt;\u20091000 copies\/mL). The prevalence of hyperuricemia was 21.3% (83\/390). Current alcohol use (adjusted prevalence ratio (aPR)\u2009=\u20092.07, 95% CI: 1.26, 3.41,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.004) and increased respiratory rate (aPR\u2009=\u20091.09, 95% CI: 1.02, 1.16,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009=\u20090.015) were independently associated with hyperuricemia. Lower oxygen saturation, duration on ART, and increased diastolic blood pressure, triglycerides, weight, BMI, and circumferences (waist, hip, neck, and mid-upper arm) were associated with hyperuricemia at bivariable analysis but lost significance after adjusting for confounders.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>One in five PLWH had hyperuricemia in this study. Alcohol use was identified as a potential modifiable risk factor for hyperuricemia. While alcohol cessation programs are needed to mitigate the risk of hyperuricemia, studies should explore the effect of hyperuricemia on lung function among PLWH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20499361251347698","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T22:43:45Z","timestamp":1750459425000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and factors associated with hyperuricemia among people living with HIV in Uganda: a cross-sectional study at a tertiary hospital in Uganda"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5507-1664","authenticated-orcid":false,"given":"Jeremiah","family":"Mutinye Kwesiga","sequence":"first","affiliation":[{"name":"Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene &amp; Tropical Medicine Uganda Research Unit P.O. Box 49, Plot 51-59 Nakiwogo Road, Entebbe, Wakiso District, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan","family":"Nkonge","sequence":"additional","affiliation":[{"name":"St Catherine\u2019s Hospital, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Namanda","sequence":"additional","affiliation":[{"name":"Makerere Lung Institute, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Nabwana","sequence":"additional","affiliation":[{"name":"Makerere University\u2014John Hopkins Research Collaboration, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-9674","authenticated-orcid":false,"given":"Joseph Baruch","family":"Baluku","sequence":"additional","affiliation":[{"name":"Makerere Lung Institute, Kampala, Uganda"},{"name":"Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1370725"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.9790\/2402-1106023742"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.124.324805"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.033369"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00273.x"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212394"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16097"},{"issue":"3","key":"e_1_3_4_9_2","first-page":"285","article-title":"Hyperuricemia, gout, and cardiovascular disease\u2013an important \u201cmuddle.\u201d","volume":"67","author":"Keenan RT","year":"2009","unstructured":"Keenan RT, Pillinger MH. Hyperuricemia, gout, and cardiovascular disease\u2013an important \u201cmuddle.\u201d Bull NYU Hosp Jt Dis 2009; 67(3): 285\u2013290.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-020-00368-z"},{"issue":"11","key":"e_1_3_4_11_2","first-page":"1880","article-title":"Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors","volume":"20","author":"Medina-Rodriguez F","year":"1993","unstructured":"Medina-Rodriguez F, Guzman C, Jara LJ, et al. Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol 1993; 20(11): 1880\u20131884.","journal-title":"J Rheumatol"},{"issue":"3","key":"e_1_3_4_12_2","first-page":"55","article-title":"Hyperuricemia and the metabolic syndrome in HIV+ adults","volume":"3","author":"Enita Zinyando RMDTZ","year":"2017","unstructured":"Enita Zinyando RMDTZ. Hyperuricemia and the metabolic syndrome in HIV+ adults. Res J Life Sci Bioinform Pharm Chem Sci [Internet] 2017; 3(3): 55\u201363.","journal-title":"Res J Life Sci Bioinform Pharm Chem Sci"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418799803"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0379-z"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224279"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2025.100523"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","unstructured":"Sullivan KM Dean A Soe MM. On Academics: OpenEpi: a web-based epidemiologic and statistical calculator for public health. Public Health Reports\u00ae. 2009; 124(3): 471\u2013474.","DOI":"10.1177\/003335490912400320"},{"key":"e_1_3_4_18_2","unstructured":"Uganda Bureau of Statistics. National population and housing census 2024 \u2013 Final Report - Volume 1 (Main). Kampala 2024."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-774"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17072451"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01916-y"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2018.03.031"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000237374.16068.de"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-074697"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2319-y"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2005.01.024"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212233072602"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111512"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(72)90115-1"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240987"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090953"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51808-y"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0891-5849(96)00030-5"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.18633\/biotecnia.v23i2.1444"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01842-3"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08530-3"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418799803"}],"container-title":["Therapeutic Advances in Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361251347698","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20499361251347698","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361251347698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:01:28Z","timestamp":1777593688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20499361251347698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":36,"alternative-id":["10.1177\/20499361251347698"],"URL":"https:\/\/doi.org\/10.1177\/20499361251347698","relation":{},"ISSN":["2049-9361","2049-937X"],"issn-type":[{"value":"2049-9361","type":"print"},{"value":"2049-937X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"article-number":"20499361251347698"}}